Growth Metrics

Fulgent Genetics (FLGT) Shares Outstanding (Diluted Average) (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Shares Outstanding (Diluted Average) for 10 consecutive years, with $30.7 million as the latest value for Q3 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 2.04% to $30.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $30.7 million through Sep 2025, up 2.04% year-over-year, with the annual reading at $31.0 million for FY2022, 0.04% changed from the prior year.
  • Shares Outstanding (Diluted Average) hit $30.7 million in Q3 2025 for Fulgent Genetics, roughly flat from $30.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $31.2 million in Q1 2022 to a low of $29.5 million in Q1 2023.
  • Historically, Shares Outstanding (Diluted Average) has averaged $30.5 million across 5 years, with a median of $30.8 million in 2021.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): skyrocketed 42.68% in 2021 and later decreased 5.45% in 2023.
  • Year by year, Shares Outstanding (Diluted Average) stood at $31.0 million in 2021, then fell by 0.04% to $31.0 million in 2022, then dropped by 3.79% to $29.8 million in 2023, then increased by 1.03% to $30.1 million in 2024, then grew by 2.04% to $30.7 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for FLGT at $30.7 million in Q3 2025, $30.7 million in Q2 2025, and $30.8 million in Q1 2025.